Labrie, Fernand,Singh, Shankar,Gauthier, Sylvain,Frechette, Yvon,Chenard, Sylvain,Breton, Rock
申请号：
AU2014274607
公开号：
AU2014274607A1
申请日:
2014.12.11
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2014274607A120150122.pdf#####ABSTRACT Compounds having the structure or their salts: are used to treat or reduce the likelihood of acquiring androgen5 dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or 10 otherwise made into any pharmaceutical dosage form. Some of these compounds having tissue-specific antiandrogenic activity and tissue-specific androgenic activity can be used to treat or reduce the risk of developing diseases related to loss of androgenic stimulation. Combinations 15 with other active pharmaceutical agents are also disclosed.
